ADC Therapeutics SA Quarterly Costs and Expenses in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
ADC Therapeutics SA quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q2 2024.
  • ADC Therapeutics SA Costs and Expenses for the quarter ending June 30, 2024 was $46.5M, a 21.2% decline year-over-year.
  • ADC Therapeutics SA annual Costs and Expenses for 2023 was $236M, a 29.3% decline from 2022.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $46.5M -$12.5M -21.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $51.7M -$17.5M -25.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q2 2023 $58.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $69.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.